An Update on the Effect of Incretin-Based Therapies on β-Cell Function and Mass
about
Efficacy and safety of adding evogliptin versus sitagliptin for metformin-treated patients with type 2 diabetes: A 24-week randomized, controlled trial with open label extensionRecent Advances in Effect-directed Enzyme Assays based on Thin-layer Chromatography.Liraglutide Enhances the Efficacy of Human Mesenchymal Stem Cells in Preserving Islet β-cell Function in Severe Non-obese Diabetic Mice.DPP-4 inhibitors in diabetic complications: role of DPP-4 beyond glucose control.Nutrient regulation of β-cell function: what do islet cell/animal studies tell us?The effects of vildagliptin compared with metformin on vascular endothelial function and metabolic parameters: a randomized, controlled trial (Sapporo Athero-Incretin Study 3).Effectiveness and safety of exenatide in Korean patients with type 2 diabetes inadequately controlled with oral hypoglycemic agents: an observational study in a real clinical practice.Antihyperglycemic agent therapy for adult patients with type 2 diabetes mellitus 2017: a position statement of the Korean Diabetes Association.Antihyperglycemic Agent Therapy for Adult Patients with Type 2 Diabetes Mellitus 2017: A Position Statement of the Korean Diabetes Association.Efficacy and safety of gemigliptin, a dipeptidyl peptidase-4 inhibitor, in patients with type 2 diabetes mellitus inadequately controlled with combination treatment of metformin and sulphonylurea: a 24-week, multicentre, randomized, double-blind, pl
P2860
Q33626226-BF31B03F-9EEF-49D4-943B-1AA637A60D02Q36266184-BF063F44-CCFD-489E-AFB5-AE92A747DAB4Q37540986-74C9A06B-FBCF-4CD4-AF9E-208B8BE9F99AQ38922177-B104F5AC-B5E6-4229-ABB6-12BFE0BAD17FQ39250322-0E11FEE6-69C4-40A4-8E1A-872C334D484CQ42374104-5493FE86-496A-4EA6-9034-87C391BA204BQ42633689-58A89447-DFAD-47FC-BF67-6E4DEE1948A5Q47094226-35BD945F-DA1D-4392-AEEA-D4BA39872D66Q47176512-00764457-476A-4BF4-980E-555E87920BBDQ51233383-E2944C43-E336-4C2E-AB97-A1D3B7774482
P2860
An Update on the Effect of Incretin-Based Therapies on β-Cell Function and Mass
description
2016 nî lūn-bûn
@nan
2016 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
An Update on the Effect of Incretin-Based Therapies on β-Cell Function and Mass
@ast
An Update on the Effect of Incretin-Based Therapies on β-Cell Function and Mass
@en
An Update on the Effect of Incretin-Based Therapies on β-Cell Function and Mass
@nl
type
label
An Update on the Effect of Incretin-Based Therapies on β-Cell Function and Mass
@ast
An Update on the Effect of Incretin-Based Therapies on β-Cell Function and Mass
@en
An Update on the Effect of Incretin-Based Therapies on β-Cell Function and Mass
@nl
prefLabel
An Update on the Effect of Incretin-Based Therapies on β-Cell Function and Mass
@ast
An Update on the Effect of Incretin-Based Therapies on β-Cell Function and Mass
@en
An Update on the Effect of Incretin-Based Therapies on β-Cell Function and Mass
@nl
P2860
P3181
P356
P1476
An Update on the Effect of Incretin-Based Therapies on β-Cell Function and Mass
@en
P2093
Jean François Gautier
P2860
P304
P3181
P356
10.4093/DMJ.2016.40.2.99
P407
P577
2016-04-01T00:00:00Z